United States · 
Who invested in Immunologix?
Immunologix's investors include South Carolina Research Authority.
2011
$200KVenture$890KVenture$251KVentureUnited States · Venture startup
Who invested in Immunologix
Funding summaryUpdated 26 Oct 2026
$1.3Mraised across 3 rounds since 2010, from 3 sources
$200KVenture$890KVenture$251KVenture
- Latest round
- Venture, $251KJul 2011
- Biggest round
- $890KVenture · Aug 2010
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $200K Mar 2010
- Biggest round
- $890K Venture · Aug 2010
- Usual gap between rounds
- 11 months the median of 2
The rounds
- Jul 2011Venture$251K
No investor was named in the report.
Reported by sec.govSEC filing: $251K sold, first sale Jul 2011
- Aug 2010Venture$890K
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Mar 2010
- Mar 2010Venture$200K1 new
Reported by immunologix.comSEC filing: $198K sold, first sale Mar 2010
The exit
ExitBuyerPriceWhen
AcquiredIntrexon CorporationundisclosedOct 2011
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immunologix
How much has Immunologix raised?
Immunologix has raised $1.3M across 3 rounds since 2010.
When did Immunologix last raise?
Immunologix's most recent round was a Venture of $251K in Jul 2011.
What was Immunologix's biggest round?
Immunologix's largest round on record is $890K (Venture), in Aug 2010.
Who backed Immunologix first?
Immunologix's first round on record, in Mar 2010, was backed by South Carolina Research Authority.
What stage is Immunologix at?
Immunologix's latest named round is a Venture, in Jul 2011.
Where is Immunologix based?
Immunologix is based in the United States.
Companies like Immunologix
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.